|
|
 |
|
Viewing report
|
|
|
|
The Prostate Cancer R&D Database
Bioseeker, Sep 2003
Decision-making requires a vast amount of structured information. Although paramount to establishing a representative description of a particular field, identifying and structuring information is a tedious task. When generating an information structure, it is essential to make it as complete as possible in order to analyze and draw correct conclusions from the field. For your convenience, BioSeeker Group has identified and structured more than 300 industry related prostate cancer R&D projects, compiled in the first edition of this database. This collection of data describes the R&D activities in this field as near completely as possible.
Compiling the information in a database file for convenient transfer of data to your preferred information system will save hundreds of working hours for you. Depending on the aim of your analysis, it will enable you to produce simple as well as advanced information analysis on the spot. Use the database to produce key tables and automated graphs in no more than a few minutes!
This is one of the world's most comprehensive and updated information sources describing the structure of the prostate cancer R&D situation. It includes information about new innovative cancer therapies such as antisense, monoclonal antibodies, gene therapies, antigen- or cellular-based vaccines, liposomal hormones and apoptotic drugs.
The information is structured in 9 different segments:
- Company
- Drug name
- Developmental stage
- Therapy given
- Effect
- Effect- Mecanism
- Mecanism- General comments
It includes information from:
More than 300 industry related prostate cancer R&D projects Information on more that 160 companies active in prostate cancer R&D Data from 170 clinical trials
Information on more than 130 preclinical projects
This part of the database will help you in:
1. Tracking cutting edge companies, therapies and new technologies
2. Producing tables and graphs in an instant, speeding up the information structure needed for your analysis
3. Rapid identification of partners and competitors
4. Laying down a comprehensive framework for further analysis of the field
5. Producing presentations surrounding the development of prostate cancer therapeutics
6. Identifying emerging prostate cancer products and key areas of
pharmaceutical R&D
BioSeeker Group will shortly expand the database with additional sections such as:
- Technology platform database
- Deal and partnership database
- Company information database
BioSeeker Group AB uses mainly primary information sources. By this we mean information that have been produced by each company, including:
- BioSeeker Group's in-house databases
- Company homepages and press releases
- Annual/quarterly reports
- Interviews with key personnel, scientists and investors
- Scientific publications
- Patent publications
- Conference abstracts and presentations
- Published interviews
Customers who bought this item also bought
Analytical Tool - Prostate Cancer
Analytical Tool - Prostate Cancer: A Therapeutic & Competitive Insight
Analysis of Prostate Cancer R&D: The Complete Guide
Currently Druggable in Prostate Cancer: A Drug Target Competitive Analysis
Prostate Cancer - A Therapeutic & Competitive Insight
Triple Analysis: Decoding Big Pharma's R&D Strategy In Oncology and Special Focus on Breast and Prostate Cancer
Triple Analysis: The Drug Target Atlas of Apoptopic Drugs in Oncology and Special Focus on Breast and Prostate Cancer
Prostate and Breast Cancer- New Treatments & Developmental Progress
Cancer Prostate Cancer
Disease and Therapy Review: Prostate Cancer
Antibody Drug Targets and Focus on Breast & Prostate Cancer
Cancer Drug Discoveries: What the Future Holds: Prostate Cancer Chapter
|
|
|
|
